erenumab (aimovig) is the first of four new migraine drugs in the pipeline that target calcitonin gene-related peptide (cgrp), a molecule that's produced in nerve cells of the
.
.
.
if you would like to add a comment, please register or log in
.
.
.
understanding cholesterol effects of adalimumab by new techniques was another goal of gelfand and mehta's study.
.